Robert Egge is the Alzheimer’s Association’s Vice President of Public Policy. With policy experience in Alzheimer’s and related healthcare
issues, Mr. Egge leads the Association’s Public Policy division based in Washington, DC. The division includes federal affairs, state affairs, public health and grassroots advocacy teams working in pursuit of policies to better serve those affected by Alzheimer’s disease and related disorders. Chief among these priorities are increasing federal support for Alzheimer’s research and treatment development, enhancing Alzheimer’s care and support, and improving Alzheimer’s planning, coordination and execution by federal and state agencies.
In his previous position as Executive Director of the Alzheimer’s Study Group, Mr. Egge led a review of the broad range of challenges posed to the nation by the mounting Alzheimer crisis, and opportunities to address them. The Alzheimer’s Study Group, a blue ribbon task force of national leaders co-chaired by former House Speaker Newt Gingrich and former Nebraska Senator Bob Kerrey, was created to develop a national strategic plan to address Alzheimer’s disease. Mr. Egge worked closely with Gingrich, Kerrey and other Alzheimer’s Study Group members including Justice Sandra Day O’Connor, Dr. Mark McClellan, Dr. Harold Varmus and Dr. David Satcher to shape and develop the group’s national assessment, strategy and specific policy proposals.
Mr. Egge’s editorials have appeared in a variety of newspapers including the New York Times, the Financial Times, and Business Week. He has also testified before various committees in the U.S. House and Senate on Alzheimer’s policy, and has given frequent television, radio and print
interviews on Alzheimer’s and other aspects of health care policy.